PULMONARY PHARMACOLOGY & THERAPEUTICS

Scope & Guideline

Transforming patient care with cutting-edge insights.

Introduction

Welcome to the PULMONARY PHARMACOLOGY & THERAPEUTICS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of PULMONARY PHARMACOLOGY & THERAPEUTICS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1094-5539
PublisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1997 to 2024
AbbreviationPULM PHARMACOL THER / Pulm. Pharmacol. Ther.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address24-28 OVAL RD, LONDON NW1 7DX, ENGLAND

Aims and Scopes

The journal 'Pulmonary Pharmacology & Therapeutics' is dedicated to advancing the understanding and treatment of respiratory diseases through the exploration of pharmacological therapies and therapeutic techniques. The journal encompasses a broad range of topics related to the pulmonary system, focusing on innovative treatments, drug delivery mechanisms, and the underlying biological mechanisms of respiratory conditions.
  1. Pharmacological Innovations in Respiratory Diseases:
    The journal emphasizes novel pharmacological agents and therapies for managing various respiratory diseases, including asthma, COPD, pulmonary hypertension, and cystic fibrosis.
  2. Drug Delivery Systems:
    A significant focus is placed on the development and evaluation of drug delivery systems, including inhalation techniques, formulations, and devices, aimed at optimizing therapeutic outcomes for respiratory conditions.
  3. Mechanistic Studies of Lung Pathophysiology:
    Research articles frequently explore the cellular and molecular mechanisms underlying lung diseases, contributing to a deeper understanding of pathophysiology and informing therapeutic strategies.
  4. Clinical Efficacy and Safety Evaluations:
    The journal publishes studies assessing the efficacy and safety of existing and emerging therapies, often through systematic reviews, meta-analyses, and real-world studies.
  5. Interdisciplinary Approaches to Respiratory Health:
    Encouraging interdisciplinary research, the journal integrates insights from pharmacology, immunology, microbiology, and clinical practice to address complex respiratory health issues.
Recent publications indicate a dynamic evolution in research themes within the journal, highlighting emerging areas of interest that reflect current challenges and advancements in pulmonary medicine.
  1. Targeted Therapies and Personalized Medicine:
    There is a growing trend towards exploring targeted therapies and personalized medicine approaches for chronic respiratory diseases, particularly in conditions like asthma and cystic fibrosis.
  2. Innovations in Drug Delivery Technologies:
    Research on novel drug delivery systems, including lipid nanoparticles and advanced inhalation devices, is trending, showcasing the need for effective and patient-friendly therapeutic options.
  3. Impact of COVID-19 on Pulmonary Pharmacotherapy:
    The ongoing implications of the COVID-19 pandemic have led to increased research on its effects on existing pulmonary disease management, including the use of existing therapies in COVID-19 patients.
  4. Role of Biomarkers in Disease Management:
    Emerging studies are increasingly focusing on the identification and utilization of biomarkers to predict treatment responses, disease progression, and therapeutic outcomes in respiratory conditions.
  5. The Intersection of Immunology and Respiratory Diseases:
    Research exploring the immunological aspects of respiratory diseases, particularly in the context of inflammation and fibrosis, is on the rise, reflecting a broader understanding of disease mechanisms.

Declining or Waning

As the journal evolves, certain themes and research areas appear to be diminishing in prominence. This decline may reflect shifts in research focus, advancements in alternative therapeutic strategies, or changing clinical practices.
  1. Traditional Antibiotic Therapies:
    Research on conventional antibiotic therapies for respiratory infections is becoming less frequent, as newer agents and novel treatment modalities gain attention and importance.
  2. Basic Research on Lung Physiology without Therapeutic Context:
    Studies purely focused on the basic physiology of lung function, without direct implications for therapeutic advancements, are appearing less often, signaling a shift towards more clinically relevant research.
  3. Generalized Asthma Management Approaches:
    While asthma remains a key area of research, there is a noticeable decline in studies focusing on generic management approaches, with a growing interest in targeted therapies and personalized medicine.

Similar Journals

Pulmonology

Pioneering insights for a healthier tomorrow in pulmonology.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Enhancing clinical outcomes through impactful research.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Exploring new frontiers in aerosol therapy.
Publisher: MARY ANN LIEBERT, INCISSN: 1941-2711Frequency: 6 issues/year

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, published by MARY ANN LIEBERT, INC, is a distinguished journal dedicated to advancing the field of aerosol medicine and pharmacology. With an ISSN of 1941-2711 and E-ISSN 1941-2703, the journal has established itself as an essential resource for researchers and professionals specializing in pharmaceutical sciences and pulmonary medicine. Ranking in the Q2 category across multiple disciplines, including Pharmaceutical Science and Pulmonary and Respiratory Medicine, it holds notable Scopus rankings, with a percentile of 78th in Pulmonary and Respiratory Medicine. The journal offers open access options, ensuring that cutting-edge research is readily available to a global audience. With converged years from 2008 to 2024, the Journal of Aerosol Medicine and Pulmonary Drug Delivery continues to serve as a vital platform for disseminating innovative research findings, clinical practice insights, and technological advancements in drug delivery systems, thereby significantly impacting therapeutic strategies for respiratory diseases.

PEDIATRIC PULMONOLOGY

Fostering collaboration to enhance outcomes in pediatric pulmonary care.
Publisher: WILEYISSN: 8755-6863Frequency: 12 issues/year

Pediatric Pulmonology is a leading journal published by Wiley, dedicated to advancing the field of pediatric respiratory medicine. With an impressive impact factor and a commitment to excellence since its inception in 1985, this quarterly publication reaches researchers, clinicians, and healthcare professionals interested in the latest findings and practices concerning pediatric pulmonary health. The journal has achieved notable rankings in prestigious databases, including Q1 in Pediatrics, Perinatology, and Child Health, and Q2 in Pulmonary and Respiratory Medicine, reflecting its high-quality contributions to the field. Celebrated for its rigorous peer-review process, Pediatric Pulmonology serves as a vital platform for disseminating significant research, clinical studies, and innovative approaches to the management of respiratory conditions in infants, children, and adolescents. This journal not only provides valuable insights but also fosters collaboration among professionals dedicated to enhancing the care and outcomes for young patients. Access to this resource is available through institutional subscriptions, further ensuring widespread dissemination of crucial research findings.

Egyptian Journal of Bronchology

Empowering knowledge exchange in bronchial medicine.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

COPD-Journal of Chronic Obstructive Pulmonary Disease

Enhancing access to vital COPD research.
Publisher: TAYLOR & FRANCIS INCISSN: 1541-2555Frequency: 6 issues/year

COPD - Journal of Chronic Obstructive Pulmonary Disease is a premier peer-reviewed journal published by Taylor & Francis Inc. that focuses on the latest advancements in the understanding, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD). As an Open Access journal since 2022, it enhances availability and dissemination of groundbreaking research, allowing researchers, healthcare professionals, and students to access vital information without barriers. The journal has established itself as a significant resource in pulmonary and respiratory medicine, boasting a commendable Q2 ranking in both medicine and specialty areas as of 2023, with an impressive Scopus rank of 66 out of 155. By bridging the gap between scientific exploration and clinical application, COPD aims to foster innovative approaches to managing this prevalent condition, making it an essential publication for those dedicated to improving patient care and advancing respiratory health.

Turkish Thoracic Journal

Empowering knowledge for better respiratory health solutions.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

BMC Pulmonary Medicine

Connecting researchers and practitioners for impactful insights.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

LUNG

Connecting researchers and clinicians in the fight against lung diseases.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

European Respiratory Review

Transforming Research into Respiratory Excellence
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0905-9180Frequency: 4 issues/year

European Respiratory Review is a prestigious peer-reviewed journal published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, specializing in the dynamic field of pulmonary and respiratory medicine. With an impact factor that places it among the top quartile journals in its category (Q1), as indicated by its impressive Scopus rank of #7 out of 155, it serves as a critical platform for disseminating high-quality research and innovative reviews in the field. As an Open Access journal since 2005, it ensures that cutting-edge findings are readily available to a global audience, promoting greater transparency and collaboration within the academic community. Published from Switzerland, European Respiratory Review covers a broad spectrum of topics from clinical advancements to emerging trends, making it an essential resource for researchers, healthcare professionals, and students committed to advancing respiratory health. The journal's history, dating back to 1992, reflects a steadfast commitment to fostering scholarly exchange and driving forward the frontiers of knowledge within respiratory medicine.